-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BmCm8RmTpoxsgS61cXgxudJqYaJ1geI9iZpC2utR/ZtiYBc0D/Ag0z98Zc6ZpWqb h8BEBJbwr7k6jnY2ekpkQg== 0001071739-07-000014.txt : 20070316 0001071739-07-000014.hdr.sgml : 20070316 20070316170200 ACCESSION NUMBER: 0001071739-07-000014 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20070315 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20070316 DATE AS OF CHANGE: 20070316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 041406317 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 07700925 BUSINESS ADDRESS: STREET 1: 7711 CARONDELET AVE CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7711 CARONDELET AVE STREET 2: SUITE 800 CITY: ST LOUIS STATE: MO ZIP: 63105 8-K 1 form8k.htm FORM 8-K Form 8-K


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
 
FORM 8-K
 

 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported): March 15, 2007
 

  
CENTENE CORPORATION
(Exact Name of Registrant as Specified in Charter)
 
 
         
Delaware
 
000-33395
 
42-1406317
(State or Other Jurisdiction of Incorporation)
 
 
(Commission File Number)
 
(IRS Employer Identification No.)
 
 
     
7711 Carondelet Avenue, Suite 800
St. Louis, Missouri
 
63105
(Address of Principal Executive Offices)
 
(Zip Code)
 
Registrant’s telephone number, including area code: (314) 725-4477
 
Former Name or Former Address, if Changed Since Last Report: Not Applicable
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 
 
 
 
 


 
Item 8.01. Other Events.
 
The Company announced the pricing of its 7 ¼% Senior Notes due 2014 in a press release dated March 16, 2007, which is attached as Exhibit 99.1 hereto and incorporated herein by reference.
 
Item 9.01. Financial Statements and Exhibits.
 
(d) Exhibits.
 
 Exhibit Number
 
 Description of Exhibit
 99.1
   Press Release dated March 16, 2007
   
 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 


 
 
 
 
 
Date: March 16, 2007
CENTENE CORPORATION
(Registrant)
 
 
 
By:  
/s/ J. PER BRODIN
 
 
 
J. Per Brodin  
 
 
 
Senior Vice President and Chief Financial Officer 
 
 
 



EXHIBIT INDEX
 
 
 Exhibit Number
 
 Description of Exhibit
     
 99.1
   Press Release dated March 16, 2007
   

 
EX-99.1 2 exhibit991.htm EXHIBIT 99.1 Exhibit 99.1
Exhibit 99.1
 
ST. LOUIS--(BUSINESS WIRE)--March 16, 2007--Centene Corporation (NYSE: CNC) today announced it priced $175 million aggregate principal amount of its 7 1/4% Senior Notes due 2014 in a private placement primarily pursuant to Rule 144A under the Securities Act of 1933 (the "Securities Act"). The offering is expected to close on or about March 22, 2007. The issuance of the notes will be subject to customary closing conditions. The Company will use a portion of the net proceeds from the offering to refinance approximately $150 million of its existing indebtedness which is currently outstanding under its revolving credit facility. Any additional proceeds will be used for general corporate purposes.
 
The notes will be offered in the United States to qualified institutional buyers pursuant to Rule 144A under the Securities Act and outside the United States to non-United States persons in compliance with Regulation S under the Securities Act. The notes have not been registered under the Securities Act and may not be offered or sold in the United States without registration or an applicable exemption from the registration requirements.
 
This press release shall not constitute an offer to sell or a solicitation of an offer to purchase any of these securities and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful.
 
This press release contains certain forward-looking statements, including without limitation, statements regarding the completion of the offering, the timing of the closing of the offering, and the use of proceeds from the offering. Such statements are subject to various risks and uncertainties that could cause actual results to differ materially, including general market conditions. The Company's reports to the SEC contain additional information relating to additional factors that could cause actual results to differ from these forward-looking statements. The Company does not undertake any obligation or plan to update these forward-looking statements, even though its situation may change.
 
About Centene Corporation
 
Centene Corporation is a leading multi-line healthcare enterprise that provides programs and related services to individuals receiving benefits under Medicaid, including Supplemental Security Income (SSI) and the State Children's Health Insurance Program (SCHIP). The Company operates health plans in Georgia, Indiana, New Jersey, Ohio, Texas and Wisconsin. In addition, the Company contracts with other healthcare and commercial organizations to provide specialty services including behavioral health, disease management, long-term care, managed vision, nurse triage, pharmacy benefit management and treatment compliance. Information regarding Centene is available via the Internet at www.centene.com.
 
 
CONTACT:
Centene Corporation
J. Per Brodin, 314-725-4477
Chief Financial Officer
or
Lisa M. Wilson, 212-759-3929
Senior Vice President, Investor Relations
SOURCE: Centene Corporation
 
-----END PRIVACY-ENHANCED MESSAGE-----